Optical oxygen sensor systems manufacturer OxySense has announced the launch of its new Sidewinder Invasive Measurement Needle, which allows users to measure headspace and dissolved oxygen in closed and opaque containers. According to the ...
Tags: optical oxygen sensor, OxySense, containers
Guided Therapeutics has completed one of two major third-party electromagnetic compatibility testings of its non-invasive cervical scan device. Using the company's patented biophotonic technology, LuViva advanced cervical scan detects ...
Kona Medical has raised additional $10m in equity and debt financing round to bring its total proceeds to $40m. The funding round, in addition to its prior investors Essex Woodlands, Domain Associates, Morgenthaler Ventures, Western ...
Tags: Kona Medical, Series C financing, ultrasound
Epigenomics has reported positive results from a clinical study, which showed that its blood-based colorectal cancer (CRC) detection test is non-inferior in sensitivity when compared to fecal immunochemical testing (FIT). Using patients ...
Tags: Epigenomics, blood-based colorectal cancer, non-inferior in sensitivity
IRIDEX has obtained FDA's 510(k) approval and CE mark for its non-invasive laser delivery system, designed for treating serious retinal diseases. Using MicroPulse technology, the new TxCell Scanning laser delivery system saves time in a ...
Tags: IRIDEX, non-invasive, laser delivery system, CE mark approvals
Guided Therapeutics has extended third consecutive year licensing agreement with Konica Minolta Technology Center to co-develop a non-invasive Barrett's Esophagus detection product. The Barrett's Esophagus product is based on the Guided ...
Tags: Guided, licensing agreement, Konica, co-develop
The European Union has granted CE mark approval to InSightec's transcranial focused ultrasound system for the treatment of essential tremor, tremor dominant Parkinson's disease and neuropathic pain. The non-invasive ExAblate Neuro ...
Tags: transcranial focused ultrasound system, Parkinson's disease
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Biosign Technologies' non-invasive blood pressure measurement system, Pulsewave monitor. The UFIT EN-10 monitor is worn on the wrist having 13.5 cm to 23 cm (5.3 ...
Tags: FDA, blood pressure measurement system, pulsewave monitor, systolic
Epigenomics has announced results from a comparative study between its blood-based colorectal cancer(CRC)detection test Epi proColon and fecal immunochemical testing(FIT)to demonstrate the non-inferiority of Epi proColon in detection of ...
Tags: Epigenomics, CRC, FIT, Epi proColon
Sequenom's European licensing partner LifeCodexx has launched its Praena test service in more than 70 prenatal clinics and hospitals in Germany, Austria, Liechtenstein and Switzerland following the CE mark approval. LifeCodexx CEO Michael ...
Tags: Praena test, LifeCodexx, Sequenom
Inovio Pharmaceuticals has received a US patent covering SynCon vaccine for cervical dysplasias and cancers caused by human papillomavirus (HPV). The patent covers Inovio's synthetic consensus HPV antigens, DNA constructs and vaccines ...
Tags: Inovio Pharmaceuticals, SynCon vaccine, HPV
Verinata Health has introduced a non-invasive prenatal test to detect autosomal and fetal sex chromosome aneuploidies for high-risk pregnancies. The expanded indication of verifi prenatal blood test detects Turner syndrome(Monosomy ...
Tags: Verinata Health, non-invasive prenatal test, high-risk pregnancies
Ariosa Diagnostics has announced the availability of Harmony prenatal test in the US and Canada through Laboratory Corporation of America Holdings (LabCorp) and Integrated Genetics. The non-invasive test uses a directed approach to ...
Tags: Integrated Genetics, non-invasive test, Harmony prenatal test
Merck Serono, a division of Merck, and Auxogyn have partnered to develop Early Embryo Viability Assessment (Eeva) test. Pursuant to the deal, Merck Serono will provide strategic, scientific and medical support for the development of ...
Tags: Early Embryo Viability Assessment test, eeva test, clinical development
Phenogen Sciences has announced the availability of BREVAGen Breast cancer risk assessment test for women at above average risk of developing estrogen-receptor positive breast cancer. The risk assessment test, which combines clinical ...
Tags: medical research, clinical technology, risk assessment test